{
  "generated_at": "2026-01-04T09:50:32Z",
  "pmid": "39641926",
  "pmc_id": "11624585",
  "tables": {
    "Table 1": {
      "label": "Table 1.",
      "title": "Frequency of Genotype-Based Phenotypes and Recommended Dose Adjustments",
      "n_rows": 8,
      "rows": [
        [
          "Patients treated with fluoropyrimidines and/or irinotecan a",
          "Control arm (n = 311), No. (%)",
          "Intervention arm (n = 252)"
        ],
        [
          "No. (%)",
          "Pharmacogenetic-informed treatment according to DPWG guidelines"
        ],
        [
          "Actionable genotype carriers",
          "23 (7.4)",
          "17 (6.7)",
          ""
        ],
        [
          "DPYD AS 0.5",
          "1 (0.3)",
          "0",
          "Avoid fluoropyrimidines or perform DPD phenotyping"
        ],
        [
          "DPYD AS 1",
          "6 (1.9)",
          "2 (0.8)",
          "50% of the standard dosage"
        ],
        [
          "DPYD AS 1.5",
          "7 (2.3)",
          "11 (4.4)",
          "50% of the standard dosage"
        ],
        [
          "UGT1A1 PM",
          "9 (2.9)",
          "4 (1.6)",
          "70% of the standard dosage"
        ],
        [
          "Nonactionable genotype carriers ( DPYD AS 2, UGT1A1 NM/IM)",
          "288 (92.6)",
          "235 (93.3)",
          "Standard dosage"
        ]
      ]
    },
    "Table 2": {
      "label": "Table 2.",
      "title": "Difference in the Incidence of Clinically Relevant Toxic Effects Between Arms a",
      "n_rows": 10,
      "rows": [
        [
          "Variable",
          "Patients, No.",
          "Patients with clinically relevant toxic effects, No. (%)",
          "OR (95% CI) b",
          "P value b"
        ],
        [
          "Any actionable genotype carriers",
          "",
          "",
          "",
          ""
        ],
        [
          "Control arm",
          "23",
          "8 (34.8)",
          "1 [Reference]",
          ".04"
        ],
        [
          "Intervention arm",
          "17",
          "1 (5.9)",
          "0.1 (0.0-0.8)"
        ],
        [
          "All patients",
          "",
          "",
          "",
          ""
        ],
        [
          "Control arm",
          "311",
          "54 (17.4)",
          "1 [Reference]",
          ".41"
        ],
        [
          "Intervention arm",
          "252",
          "37 (14.7)",
          "0.8 (0.5-1.3)"
        ],
        [
          "Subanalysis focusing only on the actionable DPYD genotype carriers",
          "",
          "",
          "",
          ""
        ],
        [
          "Control arm",
          "14",
          "5 (35.7)",
          "1 [Reference]",
          ".04"
        ],
        [
          "Intervention arm",
          "13",
          "0",
          "NA"
        ]
      ]
    }
  }
}